Maharashtra FDA Warns Bollywood Actors Over Surrogate Ads

Maharashtra Food and Drug Administration (FDA) Chief Tukaram Munde has warned of legal action against individuals associated with surrogate, false, and misleading advertisements. This comes after the FDA issued show-cause notices to Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff over their endorsement of a 'Vimal Elaichi' advertisement.

The notices were issued on Sunday, August 16, and the actors have been given 15 days to submit written replies, along with documents explaining their association with the advertisement and the due diligence undertaken before endorsing the product. The FDA alleged that the branding could amount to indirect or surrogate promotion of prohibited pan masala and tobacco products.

Munde clarified that legal action would be taken against individuals associated with any surrogate or misleading advertisement if found in violation of the regulations. He stated that this invites a fine up to Rs 10 lakh in the first stage, and if the FDA is still not satisfied, action will be taken under the FSSAI Act's clauses about prohibited items.

The FDA has also directed the actors to immediately discontinue their participation in the advertisement and remove related promotional content from their official social media accounts, websites, and other digital platforms under their control. The notices cite the food safety law, which prohibits the manufacture, storage, distribution, and sale of pan masala in Maharashtra.

The FDA's action is aimed at curbing surrogate advertisements that promote prohibited products. Munde said that there are regulations for all such surrogate, false, and misleading ads, and the FDA is working to ensure that these regulations are enforced.

The issue of surrogate advertisements has been a concern in recent times, with many celebrities endorsing products that may be prohibited or restricted. The FDA's action is seen as a step towards regulating such advertisements and ensuring that consumers are not misled.

The Maharashtra government has been taking steps to regulate the advertisement industry, and the FDA's action is part of this effort. The government has also been working to raise awareness about the dangers of tobacco and pan masala products, and the FDA's action is seen as a part of this effort.

In conclusion, the Maharashtra FDA's warning to Bollywood actors over surrogate ads is a significant step towards regulating the advertisement industry and ensuring that consumers are not misled. The FDA's action is aimed at enforcing the regulations and ensuring that individuals associated with surrogate or misleading advertisements are held accountable.

The issue of surrogate advertisements is a complex one, and it requires a coordinated effort from the government, the advertisement industry, and celebrities to ensure that consumers are not misled. The Maharashtra FDA's action is a step in the right direction, and it is hoped that it will have a positive impact on the advertisement industry.

The FDA's action is also seen as a warning to other celebrities who may be endorsing prohibited or restricted products. It is hoped that this will serve as a deterrent and ensure that celebrities are more careful when endorsing products.

Overall, the Maharashtra FDA's warning to Bollywood actors over surrogate ads is a significant step towards regulating the advertisement industry and ensuring that consumers are not misled. It is hoped that this will have a positive impact on the industry and ensure that consumers are protected from misleading advertisements.